| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | -0.16 | 0.002 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.15 | 0.004 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | -0.094 | 0.004 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |